A medical device manufacturer is ramping up production of breast biopsy needles in response to an ongoing market shortage. According to Radiology Business, the scarcity has impacted clinical workflows.
Reports from Radiology Business indicate that the United States Food and Drug Administration has signaled that this needle scarcity could potentially persist through early 2027.